Meeting
2023 ASCO Genitourinary Cancers Symposium
Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study.
Authors
Carla Miguel
SUNY Upstate Medical University, Syracuse, NY
Carla Miguel , Gennady Bratslavsky , Joseph M Jacob , Petros Grivas , Philippe E. Spiess , Andrea Necchi , Dean C. Pavlick , Richard S.P. Huang , Douglas I. Lin , Natalie Danziger , Ethan Sokol , Smruthy Sivakumar , Ryon Graf , Neil Vasan , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 258)
DOI
10.1200/JCO.2023.41.6_suppl.258
Abstract #
258
Poster Bd #
J15
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Genomic classification of clinically advanced major genito-urinary cancers (GUca) based on methylthioadenosine phosphorylase (MTAP) genomic loss.
First Author: Philippe E. Spiess
Poster
2021 Genitourinary Cancers Symposium
HHV-8 positive clinically advanced castrate-resistant prostate cancer (mCRPC): A potentially distinct molecular subset.
First Author: Petros Grivas
Poster
2022 ASCO Annual Meeting
Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC).
First Author: Petros Grivas
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi